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Objectives
To determine whether the extent of myocardial fibrosis
by late-gadolinium enhancement cardiovascular mag-
netic resonance (LGE-CMR), and echocardiographic
ventricular dyssynchrony can independently predict
response to medical therapy in patients with newly-diag-
nosed idiopathic dilated cardiomyopathy (DCM).
Background
Myocardial fibrosis and ventricular dyssynchrony are
frequent findings in DCM. Although previous studies
have reported poor prognosis with the presence of myo-
cardial fibrosis in DCM, they focussed on patients with
established cardiomyopathy, and did not characterise
patients early in the disease course and may not
have included those with significant improvement in
LV function soon after diagnosis. Hence, the degree of
myocardial fibrosis and ventricular dyssynchrony at
initial presentation, and their role in perpetuating left
ventricular (LV) dysfunction in DCM remains unclear.
We hypothesised that extent of myocardial fibrosis by
the LGE-CMR technique and echocardiographic ventri-
cular dyssynchrony are independent predictors of failure
of improvement in LV function in new-onset DCM.
Methods
Patients with a new diagnosis of DCM (LV ejection
fraction (EF) ≤45%) made within the preceding two weeks
were recruited. Patients underwent LGE-CMR, echocar-
diography, 6-minute-walk testing, cardiopulmonary exer-
cise testing, and blood sampling for measurement of
serum NT-pro-BNP concentration at baseline. Baseline
patient characteristics were compared with a cohort of
healthy volunteers. Myocardial fibrosis by LGE-CMR was
identified by experienced observers blinded to patient out-
come, and was quantified by planimetry for calculation of
fibrosis mass. LV systolic function was reassessed after 5
months optimal medical therapy.
Results
Sixty-eight patients with DCM and 19 healthy volunteers
were studied. DCM patients were studied a median 12.5
days following diagnosis. Compared to healthy controls,
DCM patients exhibited poorer functional capacity,
higher serum NT-pro-BNP concentration, and greater
inter- and intraventricular dyssynchrony. Twenty-four
percent of DCM patients exhibited LGE at diagnosis,
whereas no LGE was observed amongst controls. Within
DCM patients with LGE, the mean fibrosis mass was 2.2
±1.3g. On multivariate analysis, strain dyssynchrony
index, and fibrosis mass were independent predictors of
change in LVEF over time (p≤0.001) (Table 1). LGE-
CMR conferred additive prognostic value over and above
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diction of improvement in LVEF.
Conclusions
The extent of myocardial fibrosis is a powerful predictor
of a negative response to medical therapy in new-pre-
sentation DCM, and LGE-CMR may thus be an impor-
tant risk-stratifying investi g a t i o ni nt h e s ep a t i e n t s .
Accurate risk stratification may permit more targeted
pharmacological and device therapies for patients with
newly-diagnosed DCM.
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Table 1 Uni- and Multivariate Model of Prognostic Factors for Change in LVEF
Variable Univariate model Multivariate model
Coefficient (95% CI) p-value Coefficient (95% CI) p-value
Age -0.06 (-0.3 to 0.2) 0.8
Gender -4 (-10 to 3) 0.8
6-minute walk distance (m) 0.03 (-0.01 to 0.08) 0.3
VO2 PEAK (mL/kg/min) 0.3 (-0.7 to 1.3) 0.6
Tissue Doppler dyssynchrony index (ms) -0.07 (-0.3 to 0.2) 0.7
E/E’ 0.04 (-0.2 to 0.3) 0.8
Left atrial volume (mL) -0.02 (-0.1 to 0.1) 0.8
TAPSE (cm) -1 (-10 to 7) 0.7
Interventricular mechanical delay (ms) -0.1 (-0.3 to 0.05) 0.3 0.3 (-0.06 to 0.6) 0.1
NT-pro BNP (μg/L) -1 (-2 to -0.09) 0.007 -0.2 (-2 to 1) 0.8
QRS-duration (ms) -0.14 (-0.3 to -0.02) 0.004 -0.3 (-0.7 to 0.1) 0.2
Strain dyssynchrony index (ms) -0.1 (-0.2 to -0.06) 0.04 -0.1 (-0.2 to -0.04) <0.001
Fibrosis mass (g) -7 (-11 to -3) <0.001 -7 (-11 to -4) <0.001
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